iNO as Salvage Treatment of Hypoxemia After TAAD Surgery
NCT04032366 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2020-02-05
Summary
The purpose of this study was to clarify the possible mechanism of hypoxemia after surgical treatment of type A acute aortic dissection and the possible mechanism of the treatment role of inhaled nitric oxide in refractory hypoxemia.
Conditions
- Type A Aortic Dissection
Interventions
- DRUG
-
inhaled nitric oxide
using of inhaled nitric oxide
- DEVICE
-
PEEP
increasing PEEP or decreasing PEEP
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
lead OTHER
Principal Investigators
-
Guo-wei Tu, PhD · Fudan University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- China
Study Locations
More Related Trials
-
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT07234032 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Iloprost in High Risk Cardiac Surgical Patients
NCT00927654 ·Status: COMPLETED ·Phase: PHASE3
-
Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)
NCT01070745 ·Status: WITHDRAWN ·Phase: PHASE2
-
Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery
NCT00235521 ·Status: COMPLETED ·Phase: NA
-
Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)
NCT01598441 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes
NCT03081052 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
NCT04231084 ·Status: COMPLETED ·Phase: PHASE4
-
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
NCT00705133 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest
NCT03079102 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Intraoperative Iloprost Inhalant on Hemodynamic Stability in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery
NCT04598191 ·Status: UNKNOWN ·Phase: NA
-
iNO300 Therapy in Critically Ill Patients With Pneumonia
NCT06950294 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension
NCT00641836 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
NCT00372346 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
NCT02725372 ·Status: TERMINATED ·Phase: PHASE3
-
VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB
NCT03122730 ·Status: COMPLETED ·Phase: PHASE2
-
Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole Hydrochloride
NCT03410420 ·Status: COMPLETED ·Phase: PHASE1
-
Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension
NCT00314548 ·Status: COMPLETED ·Phase: NA
-
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
NCT01457781 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
NCT00409526 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension
NCT07177703 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)
NCT00120380 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude
NCT00724321 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation
NCT02490657 ·Status: COMPLETED ·Phase: NA
-
Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia
NCT01449253 ·Status: UNKNOWN ·Phase: PHASE4
-
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
NCT01728220 ·Status: COMPLETED ·Phase: PHASE2